Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             240 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 94* A commercial garlic preparation exerts global inhibition of the quorum sensing (QS) system and virulence factor production of laboratory and clinical strains of Pseudomonas aeruginosa Hurley, M.N.
 2011
 10 S1 p. S24-
1 p.
 artikel
2 156 Adaptive metabolic changes in Pseudomonas aeruginosa during cystic fibrosis lung infection Jørgensen, K.M.
 2011
 10 S1 p. S39-
1 p.
 artikel
3 74 Adherence to rhDNase inhaled via an AKITA2® APIXNEB device during a clinical trial Kroneberg, P.
 2011
 10 S1 p. S19-
1 p.
 artikel
4 215 Adherence with TOBI® among cystic fibrosis patients with Pseudomonas aeruginosa infection Joish, V.N.
 2011
 10 S1 p. S55-
1 p.
 artikel
5 293 Administration of CREON(r) pellets via gastrostomy tube (G-Tube) without loss of gastric resistance or lipase activity Shlieout, G.
 2011
 10 S1 p. S74-
1 p.
 artikel
6 368* Aetiology of erectile dysfunction in cystic fibrosis Wat, D.
 2011
 10 S1 p. S94-
1 p.
 artikel
7 180 Airway inflammation in cystic fibrosis patients sensitized to Aspergillus Zissler, U.
 2011
 10 S1 p. S45-
1 p.
 artikel
8 233 Allergies in children with cystic fibrosis Ciuca, I.
 2011
 10 S1 p. S59-
1 p.
 artikel
9 172 Alpha-lipoic acid as a potential anti-inflammatory treatment in cystic fibrosis Gavina, M.
 2011
 10 S1 p. S43-
1 p.
 artikel
10 225 Analysis of bacterial pathogens before and after lung transplantation in cystic fibrosis patients Ravenni, N.
 2011
 10 S1 p. S57-
1 p.
 artikel
11 313* An audit of long term complication screening for cystic fibrosis related diabetes: the ticking time bomb! Dyce, P.
 2011
 10 S1 p. S79-
1 p.
 artikel
12 95 An audit of the investigation, antibiotic management and clinical outcome of pulmonary exacerbations in patients with cystic fibrosis Hurley, M.N.
 2011
 10 S1 p. S25-
1 p.
 artikel
13 232 A new method for monitoring spirometry – implications for cystic fibrosis care Peat, R.
 2011
 10 S1 p. S59-
1 p.
 artikel
14 240 An investigation into microbial contamination of non-invasive ventilation (NIV) devices used in adults with cystic fibrosis (CF) Cameron, S.
 2011
 10 S1 p. S61-
1 p.
 artikel
15 72 An open-label study of recombinant human BSSL (rhBSSL) in adult patients with cystic fibrosis (CF) and pancreatic insufficiency (PI) Langendonk, J.
 2011
 10 S1 p. S19-
1 p.
 artikel
16 105 Antibiotic dosing strategies of colistin on biofilm growing Pseudomonas aeruginosa: pharmacokinetic and pharmacodynamic issues Wang, H.
 2011
 10 S1 p. S27-
1 p.
 artikel
17 104 Antibiotic use in years preceding chronic lung infection with multiresistant Pseudomonas aeruginosa Vermeulen, F.
 2011
 10 S1 p. S27-
1 p.
 artikel
18 359 Anxiety and depression in Belgian patients with cystic fibrosis (CF) and their parents: a major national epidemiological study Lambrecht, P.
 2011
 10 S1 p. S91-
1 p.
 artikel
19 122 A one-year experience of routine identification by MALDI-TOF MS of non-fermenting Gram-negative rods recovered from respiratory samples from cystic fibrosis patients Olmos, A. Fernandez
 2011
 10 S1 p. S31-
1 p.
 artikel
20 80* A randomised, double-blind, placebo-controlled parallel group study to investigate the safety and efficacy of two doses of tiotropium bromide (2.5 μg and 5 μg) administered once daily via the Respimat® device for 12 weeks in patients with cystic fibrosis Elborn, J.S.
 2011
 10 S1 p. S21-
1 p.
 artikel
21 353 Are elastomeric diffusers delivering what they claim? Vigier, J.-P
 2011
 10 S1 p. S90-
1 p.
 artikel
22 176 A role of host cytosolic phospholipase A2 in acute lung infection by Pseudomonas aeruginosa Wu, Y.
 2011
 10 S1 p. S44-
1 p.
 artikel
23 114* Aspergillus fumigatus susceptibility to itraconazole in adult patients with cystic fibrosis Amsellem, M.
 2011
 10 S1 p. S29-
1 p.
 artikel
24 323 Association of treatment satisfaction and compliance of cystic fibrosis (CF) patients using inhaled tobramycin treatment in the EAGER study Regnault, A.
 2011
 10 S1 p. S82-
1 p.
 artikel
25 354* Associations between treatment non-adherence and beliefs about medicines in cystic fibrosis Abbott, J.
 2011
 10 S1 p. S90-
1 p.
 artikel
26 352 A teamwork on a multiregional network: an experience about harmonizing homecare practices for intravenous antibiotic on an implantable catheter port Kerbrat, M.
 2011
 10 S1 p. S90-
1 p.
 artikel
27 358 A ten year audit of clinical psychology referrals in the regional adult cystic fibrosis unit in Northern Ireland Crossan, A.
 2011
 10 S1 p. S91-
1 p.
 artikel
28 119 Audit review of the microbiology results of cystic fibrosis patients attending a tertiary centre clinic Dhawan, V
 2011
 10 S1 p. S30-
1 p.
 artikel
29 Author Index 2011
 10 S1 p. S103-S110
8 p.
 artikel
30 357 A 10 year retrospective audit of clinical psychology referrals within a paediatric cystic fibrosis (CF) team Russo, K.
 2011
 10 S1 p. S91-
1 p.
 artikel
31 84 Aztreonam 75 mg powder and solvent for nebuliser solution (AZLI) in cystic fibrosis (CF) patients with chronic Burkholderia species (Burk) infection: baseline demographics and microbiology from a randomized, placebo-controlled trial Tullis, E.
 2011
 10 S1 p. S22-
1 p.
 artikel
32 169* Bactericidal activity of human cystic fibrosis macrophages against Pseudomonas aeruginosa Cifani, N.
 2011
 10 S1 p. S43-
1 p.
 artikel
33 184* Basophil CD203c as a potential clinically relevant biomarker in cystic fibrosis and allergic bronchopulmonary aspergillosis Gernez, Y.
 2011
 10 S1 p. S46-
1 p.
 artikel
34 392 Brave lung: non invasive ventilation (NIV) and pneumothorax Gambazza, S.
 2011
 10 S1 p. S101-
1 p.
 artikel
35 112 Can vancomycin injection be nebulised successfully? Bevan, A.
 2011
 10 S1 p. S29-
1 p.
 artikel
36 315* Cardiac autonomic neuropathy (CAN) is more likely to occur in cystic fibrosis (CF) patients with or without diabetes than in patients with type 1 diabetes (T1DM) Rashid, R.
 2011
 10 S1 p. S80-
1 p.
 artikel
37 47 CFTR gene mutations and the risk for developing a pancreatic cancer: is it only a consequence of chronic inflammation? Alghisi, F.
 2011
 10 S1 p. S12-
1 p.
 artikel
38 146 Chronic Aspergillus fumigatus colonisation of the cystic fibrosis airway is common and may be associated with a more rapid decline in lung function Saunders, R.
 2011
 10 S1 p. S37-
1 p.
 artikel
39 374 Clinical and demographic characteristics of Estonian cystic fibrosis patients Vasar, M.
 2011
 10 S1 p. S96-
1 p.
 artikel
40 38 Clinical outcomes of newborn screening for cystic fibrosis in Russia Kusova, Z.
 2011
 10 S1 p. S10-
1 p.
 artikel
41 347* Communication and information about reproductive and sexual health in cystic fibrosis: a review Havermans, T.
 2011
 10 S1 p. S88-
1 p.
 artikel
42 108 Comparative in vitro characterisation of colistimethate sodium 1 MIU/3 ml versus 2 MIU/4 ml in an eFlow® rapid Nebuliser Bucholski, A.
 2011
 10 S1 p. S28-
1 p.
 artikel
43 1* Comparison of bioinformatics, reporter minigene and mRNA study to analyse the effect of unclassified variants on CFTR mRNA splicing Audrézet, M.-P.
 2011
 10 S1 p. S1-
1 p.
 artikel
44 281 Comparison of nutritional status of cystic fibrosis (CF) and non CF children in Albania Vevecka, E.
 2011
 10 S1 p. S71-
1 p.
 artikel
45 125* Comparison of real time diagnostic chemistries to detect early and chronic Pseudomonas aeruginosa colonisation in cystic fibrosis patients Fothergill, J.L.
 2011
 10 S1 p. S32-
1 p.
 artikel
46 64* Correction o ΔF508-CFTR in human airway epithelia and ex vivo rectal biopsies by s-cis-locked bithiazole corrector-29 Derichs, N.
 2011
 10 S1 p. S17-
1 p.
 artikel
47 308 Correction of low bone mass density in patients with cystic fibrosis Sciuca, S.
 2011
 10 S1 p. S78-
1 p.
 artikel
48 252* Correlation of physical performance and quality of life in adult patients with cystic fibrosis Hofer, M.
 2011
 10 S1 p. S64-
1 p.
 artikel
49 393* CPAP for atelectasis in bronchopulmonary aspergillosis Gambazza, S.
 2011
 10 S1 p. S101-
1 p.
 artikel
50 164 Cystic fibrosis bacterial pathogens and Aspergillus fumigatus biofilm interactions McCulloch, E.
 2011
 10 S1 p. S41-
1 p.
 artikel
51 193 Cystic fibrosis (CF) and non-CF bronchiectasis: a cross-sectional comparison Leonard, A.
 2011
 10 S1 p. S49-
1 p.
 artikel
52 380 Cystic fibrosis in Libya: the experience of an international collaboration project Repetto, T.
 2011
 10 S1 p. S97-
1 p.
 artikel
53 394 Cystic fibrosis liver disease: an emerging clinical issue showing a multifactorial pathogenesis Alghisi, F.
 2011
 10 S1 p. S101-
1 p.
 artikel
54 34* Cystic fibrosis newborn screened false-negative cohort: a national long term survey Munck, A.
 2011
 10 S1 p. S9-
1 p.
 artikel
55 366* Cystic fibrosis newborn screening: facilitating family centred care Fairservice, L.
 2011
 10 S1 p. S93-
1 p.
 artikel
56 283 Cystic fibrosis: the thicker, the better? A retrospective longitudinal study over 10 years Wiedemann, K.
 2011
 10 S1 p. S72-
1 p.
 artikel
57 345* Decision making in young adults with cystic fibrosis (CF) about risk of infection: a vignette study Reynolds, L.
 2011
 10 S1 p. S88-
1 p.
 artikel
58 388 Detection of a novel CFTR mutation c.122C>G (p.Pro41Arg) in a young cystic fibrosis (CF) patient with recurrent respiratory symptoms De Wachter, E.
 2011
 10 S1 p. S100-
1 p.
 artikel
59 369* Developing a measure of eating attitudes and behaviours in cystic fibrosis Bryon, M.
 2011
 10 S1 p. S94-
1 p.
 artikel
60 351 Developing a self-assessment transition tool for young people with cystic fibrosis Mees, C.
 2011
 10 S1 p. S89-
1 p.
 artikel
61 139 Diagnosis of nontuberculous mycobacteria infection in cystic fibrosis: how to decontaminate respiratory samples? De Bel, A.
 2011
 10 S1 p. S35-
1 p.
 artikel
62 23 Differences in blood immunoreactive trypsinogen concentrations and genotype in hypertrypsinaemic neonates Seia, M.
 2011
 10 S1 p. S6-
1 p.
 artikel
63 280 Do children with cystic fibrosis really need more energy? Jones, K.
 2011
 10 S1 p. S73-
1 p.
 artikel
64 42 Do false positive test results for newborn screening for cystic fibrosis lead to long term parental anxiety? Vernooij-van Langen, A.M.
 2011
 10 S1 p. S11-
1 p.
 artikel
65 242 Effectiveness of universal tubing at generating positive expiratory pressure in children: a pilot study Carella, E.
 2011
 10 S1 p. S61-
1 p.
 artikel
66 266 Effect of IV antibiotics on ventilation and heart rate during sleep measured by respiratory inductive plethysmography Kent, L.
 2011
 10 S1 p. S67-
1 p.
 artikel
67 116 Effect of nebulised antibiotics on Aspergillus colonisation and complications Lumb, C.
 2011
 10 S1 p. S30-
1 p.
 artikel
68 329* Effects of clinical variables and social status on clinic defaulting in adult CF (cystic fibrosis) patients Ashish, A.
 2011
 10 S1 p. S84-
1 p.
 artikel
69 59 Effects of RV1088, a novel narrow spectrum kinase inhibitor, on pro-inflammatory cytokine production in epithelial cells isolated from patients with cystic fibrosis Coates, M.
 2011
 10 S1 p. S16-
1 p.
 artikel
70 390 Efficacy and safety of colistin for inhalation in children 5 years old and younger with cystic fibrosis with Pseudomonas aeruginosa infection Nikonova, V
 2011
 10 S1 p. S100-
1 p.
 artikel
71 190 Elevated specific IgG against colomycin in patients with neurotoxicity Whitaker, P.
 2011
 10 S1 p. S48-
1 p.
 artikel
72 362 Emotional condition in the family of child and adolescent cystic fibrosis (CF) patients Catastini, P.
 2011
 10 S1 p. S92-
1 p.
 artikel
73 386 End of life care for people with cystic fibrosis (CF) May, A.
 2011
 10 S1 p. S99-
1 p.
 artikel
74 340 Enjoying learning – CF school can be fun! Rozenfeld, S.
 2011
 10 S1 p. S87-
1 p.
 artikel
75 206 Eosinopenia and severity of pulmonary exacerbations in adult cystic fibrosis patients Williams, K.
 2011
 10 S1 p. S52-
1 p.
 artikel
76 120 Epidemiology and identification of non-lactose fermenter bacteria in an adult cystic fibrosis centre Salmon, A.
 2011
 10 S1 p. S31-
1 p.
 artikel
77 26 Establishment of borderline sweat chloride concentrations: statistical analysis of long-term Czech data Vavrova, V
 2011
 10 S1 p. S7-
1 p.
 artikel
78 296 Evaluating the use of megestrol acetate in Caen and Lisieux CF Centers (2007–2010) Guillot, M.V.
 2011
 10 S1 p. S75-
1 p.
 artikel
79 165 Evaluation of antibody against Pseudomonas aeruginosa in intermittently infected cystic fibrosis patients Dolce, D.
 2011
 10 S1 p. S42-
1 p.
 artikel
80 275 Evaluation of cystic fibrosis (CF) liver disease and the indication and effect of ursodeoxycholic acid in a Dutch CF patient cohort Bronsveld, I.
 2011
 10 S1 p. S70-
1 p.
 artikel
81 371* Evidence of decline in cystic fibrosis (CF) incidence: study over a 40-year period Scotet, V
 2011
 10 S1 p. S95-
1 p.
 artikel
82 253* Exercise physiologic response during three different video games in cystic fibrosis patients del Corral Núñez-Flores, T.
 2011
 10 S1 p. S64-
1 p.
 artikel
83 182 Exhaled breath condensate (EBC) oxidative stress in children with cystic fibrosis Bui, S.
 2011
 10 S1 p. S46-
1 p.
 artikel
84 365 Expectations and needs of cystic fibrosis (CF) patients and the CF center's response Cafaggi, M.
 2011
 10 S1 p. S93-
1 p.
 artikel
85 375 Expression of cystic fibrosis (CF) at diagnosis in a reference center in Rio de Janeiro Schwan, P.J.
 2011
 10 S1 p. S96-
1 p.
 artikel
86 177* Expression of the NF-κB inhibitor A20 reflects cystic fibrosis disease severity Kelly, C.
 2011
 10 S1 p. S45-
1 p.
 artikel
87 330* Factors predicting outcome in adolescents with cystic fibrosis (CF) after transition to adult care Javellana, A.D.L.
 2011
 10 S1 p. S84-
1 p.
 artikel
88 333 FEV1 presented as graphs, does this improve understanding of respiratory function and improve treatment adherence? Raeside, F.
 2011
 10 S1 p. S85-
1 p.
 artikel
89 250* Field tests to assess exercise capacity in cystic fibrosis children Cazzarolli, C.
 2011
 10 S1 p. S63-
1 p.
 artikel
90 155 Fluctuating levels of pyocyanin in cystic fibrosis patient sputum from stable and acute samples Fothergill, J.L.
 2011
 10 S1 p. S39-
1 p.
 artikel
91 319 Funding helps lift the barriers to dietetics as the “Cinderella” profession in cystic fibrosis care McCabe, H.
 2011
 10 S1 p. S81-
1 p.
 artikel
92 57* Generation of new lung-specific tet-dependent activator mice for tight and quantitative control of conditional gene expression in the murine lung Duerr, J.
 2011
 10 S1 p. S15-
1 p.
 artikel
93 15 Genotype-phenotype correlation in cystic fibrosis patients in Slovakia – novel mutations Kayserová, H.
 2011
 10 S1 p. S4-
1 p.
 artikel
94 14 Genotype-phenotype correlations of the recurrent mRNA intron 6b splicing defect, 1002-1113_1110delGAAT Costa, C.
 2011
 10 S1 p. S4-
1 p.
 artikel
95 346* Health related quality of life (HRQoL) and health utility in patients with cystic fibrosis (CF) and chronic Pseudomonas aeruginosa (PA) infection in the UK Bradley, J.
 2011
 10 S1 p. S88-
1 p.
 artikel
96 294 High requirement of pancreatic enzyme dose Araujo, M.
 2011
 10 S1 p. S75-
1 p.
 artikel
97 149* 2009 H1N1 influenza A in cystic fibrosis patients. A French collaborative study Bucher, J.
 2011
 10 S1 p. S38-
1 p.
 artikel
98 267 Hygienic measures at a physiotherapy practice Könecke, K.
 2011
 10 S1 p. S67-
1 p.
 artikel
99 162* Identical obligate anaerobic bacteria in periodontal pockets and sputum of cystic fibrosis patients Huse, A.
 2011
 10 S1 p. S41-
1 p.
 artikel
100 121 Identification of biochemically inert non-fermentative bacteria by MALDI-TOF MS van Veen, S.Q.
 2011
 10 S1 p. S31-
1 p.
 artikel
101 150 Identification of human coronaviruses among Brazilian children with cystic fibrosis Zerbinati, R.M.
 2011
 10 S1 p. S38-
1 p.
 artikel
102 123 Identification of the main cystic fibrosis pulmonary pathogens by SNuPE (single nucleotide primer extension) Perrin, E.
 2011
 10 S1 p. S31-
1 p.
 artikel
103 187 Immunoglobulin levels in cystic fibrosis patients: influence of age and disease severity Jakovska-Maretti, T.
 2011
 10 S1 p. S47-
1 p.
 artikel
104 341 Implementation and evaluation of a therapeutic educational multidisciplinary program within the paediatric clinic for cystic fibrosis Kernen, Y.
 2011
 10 S1 p. S87-
1 p.
 artikel
105 280 Improved early life nutritional outcomes in 303 patients diagnosed with cystic fibrosis from the UK over the last 15 years Verling, W.
 2011
 10 S1 p. S71-
1 p.
 artikel
106 370* Increasing incidence of cystic fibrosis being diagnosed in adulthood over time: an analysis of two decades of care Weir, M.
 2011
 10 S1 p. S95-
1 p.
 artikel
107 244* Influence of inhaled hypertonic saline (NaCI 6%) before or during autogenic drainage on sputum weight, oxygen saturation, heart frequency and dyspnoea in cystic fibrosis patients Van Ginderdeuren, F.
 2011
 10 S1 p. S62-
1 p.
 artikel
108 79 Inhaled dry powder mannitol in cystic fibrosis (CF): the microbiology demographics and results from the phase III studies (CF301 and CF302) Bilton, D.
 2011
 10 S1 p. S20-
1 p.
 artikel
109 81* Inhaled L-arginine in patients with cystic fibrosis – a randomized controlled trial Grasemann, H.
 2011
 10 S1 p. S21-
1 p.
 artikel
110 48 Insights into the transmission interfaces of human CFTR from molecular modeling Mornon, J.-P.
 2011
 10 S1 p. S13-
1 p.
 artikel
111 306* Interaction of fat-soluble vitamins with immunosuppressant drugs in lung transplanted cystic fibrosis patients Pincikova, T.
 2011
 10 S1 p. S77-
1 p.
 artikel
112 158 In vitro co-culture of Pseudomonas aeruginosa and Prevotella spp.: Interaction between bacteria common to cystic fibrosis lung infection Einarsson, G.G.
 2011
 10 S1 p. S40-
1 p.
 artikel
113 107 In vitro susceptibility of Pseudomonas aeruginosa (PA) does not predict clinical response to aztreonam 75 mg powder and solvent for nebuliser solution (AZLI): a responder analysis in subjects with cystic fibrosis (CF) Pressler, T.
 2011
 10 S1 p. S27-
1 p.
 artikel
114 251 Is there a relation between a cardiopulmonary exercise test and a performance test in children with cystic fibrosis? Ruigrok, C.A.G.
 2011
 10 S1 p. S63-
1 p.
 artikel
115 309 Lactose intolerance is a risk factor for decreased bone mineral density in pancreatic insufficient cystic fibrosis children Madry, E.
 2011
 10 S1 p. S78-
1 p.
 artikel
116 192 Late diagnosed cystic fibrosis (CF) in patients with bronchiectasis and normal sweat tests: the D1152H mutation Miller, J.
 2011
 10 S1 p. S49-
1 p.
 artikel
117 88 Levofloxacin pharmacokinetics (PK) after administration of MP-376 (Levofloxacin inhalation solution; Aeroquin) in children with cystic fibrosis (CF) Kearns, G.L.
 2011
 10 S1 p. S23-
1 p.
 artikel
118 197 Longitudinal assessment of Pseudomonas aeruginosa in children with cystic fibrosis. Differences with healthy infants Valdesoiro-Navarrete, L.
 2011
 10 S1 p. S50-
1 p.
 artikel
119 216 Long-term inhaled ampicillin for the treatment of methicillin-susceptible Staphylococcus aureus bronchopulmonary infection in cystic fibrosis patients Lamas, A.
 2011
 10 S1 p. S55-
1 p.
 artikel
120 276* Long-term pulmonary outcome in cystic fibrosis (CF) is not adversely affected in CF associated liver disease treated with UDCA Kappler, M.
 2011
 10 S1 p. S70-
1 p.
 artikel
121 50* Low temperature and chemical rescue affect the molecular proximity of DF508-CFTR and ENaC Rennolds, J.
 2011
 10 S1 p. S13-
1 p.
 artikel
122 211* Lung clearance index (LCI) as a tool to assess the effect of antibiotics among preschoolers with cystic fibrosis Hatziagorou, E.
 2011
 10 S1 p. S54-
1 p.
 artikel
123 226 Lung transplant patients with cystic fibrosis attain lower blood concentrations of cyclosporine compared to other lung transplant patients Qvist, T.
 2011
 10 S1 p. S57-
1 p.
 artikel
124 191* Magnetic resonance imaging (MRI) as a non-invasive, radiation-free imaging modality to study the onset and progression of lung disease in infants and young children with cystic fibrosis Fritzsching, E.
 2011
 10 S1 p. S49-
1 p.
 artikel
125 76 Mannitol inhaler device culture: no evidence of an increased microbiological contamination Aitken, M.
 2011
 10 S1 p. S20-
1 p.
 artikel
126 249 Maximal steady state treadmill testing as a guide to assessment for lung transplantation in cystic fibrosis Morris, A.R.
 2011
 10 S1 p. S63-
1 p.
 artikel
127 45* Meconium ileus in cystic fibrosis newborn screening (CF NBS) Sands, P.
 2011
 10 S1 p. S11-
1 p.
 artikel
128 118* Microbial diversity in the cystic fibrosis lung – assessing the limitations of current diagnostic microbiology and antibiotic susceptibility profiling Parch, S.E.
 2011
 10 S1 p. S30-
1 p.
 artikel
129 82* Microbiological and clinical response to tobramycin inhalation powder (TIP(tm)) in cystic fibrosis patients with chronic Pseudomonas aeruginosa (Pa) infection Geller, D.E.
 2011
 10 S1 p. S21-
1 p.
 artikel
130 237 Modern physiotherapy for 0–7 years old at the CF centre Lund, Sweden Mårtensson, M.
 2011
 10 S1 p. S60-
1 p.
 artikel
131 31 Modified nasal catheter for measurement of nasal potential difference improves reproducibility Vermeulen, F.
 2011
 10 S1 p. S8-
1 p.
 artikel
132 134* Molecular characterization of methicillin-resistant Staphylococcus aureus (MRSA) strains responsible for the first infection in cystic fibrosis patients Cocchi, P.
 2011
 10 S1 p. S34-
1 p.
 artikel
133 163 Molecular investigation of Herbaspirillum as a novel pathogen in cystic fibrosis (CF) sputae and its in vivo virulence in the Galleria mellonella model Murphy, M.
 2011
 10 S1 p. S41-
1 p.
 artikel
134 219* Monitoring cystic fibrosis patient's adherence to nebulized antibiotics with the i-neb adaptive aerosol delivery (AAD) system Gartner, S.
 2011
 10 S1 p. S56-
1 p.
 artikel
135 360 Mothers' and fathers' depression: how much cystic fibrosis (CF) or other variables affect it Catastini, P.
 2011
 10 S1 p. S92-
1 p.
 artikel
136 367 Motivational interviewing (Ml); evaluating the learning outcomes of UK CF team training Duff, A.
 2011
 10 S1 p. S93-
1 p.
 artikel
137 7 Mutation analysis of CFTR gene in a region of North of France: uncommon and novel mutations Loeuille, G.-A.L.
 2011
 10 S1 p. S2-
1 p.
 artikel
138 218 Nebulised aztreonam lysine (Cayston®). A review of the first 14 months of use Shaw, N.J.
 2011
 10 S1 p. S55-
1 p.
 artikel
139 270* Neuroendocrine characterization of the intestine of F508del CFTR mice Hielte, L.
 2011
 10 S1 p. S69-
1 p.
 artikel
140 36 Newborn screening for cystic fibrosis in autonomous province of Vojvodina, Serbia, pilot study Dautovic, G. Vilotijevic
 2011
 10 S1 p. S9-
1 p.
 artikel
141 312* New onset diabetes after lung transplantation in patients with cystic fibrosis compared with patients suffering from other lung diseases van Meerkerk, G.
 2011
 10 S1 p. S79-
1 p.
 artikel
142 96 New potential antibiotic sources for Burkholderia cepacia Papaleo, M.C.
 2011
 10 S1 p. S25-
1 p.
 artikel
143 186* Nitrous oxide production in sputum from cystic fibrosis patients with chronic P. aeruginosa lung infection Kolpen, M.
 2011
 10 S1 p. S47-
1 p.
 artikel
144 262* Non-invasive (NI) rehabilitation program in cystic fibrosis patients with urinary incontinence Donà, M.
 2011
 10 S1 p. S66-
1 p.
 artikel
145 132 Non-respiratory swabs have little role in the detection of methicillin resistant Staphylococcus aureus in cystic fibrosis Horsley, A.
 2011
 10 S1 p. S34-
1 p.
 artikel
146 224 Nontuberculous mycobacterial infections among cystic fibrosis patients undergoing lung transplantation Qvist, T.
 2011
 10 S1 p. S57-
1 p.
 artikel
147 314* Occurrence of microalbuminuria in cystic fibrosis-related diabetes (CFRD) and its clinical significance Haris, M.
 2011
 10 S1 p. S79-
1 p.
 artikel
148 214 Open-label study: a comparison of breathing modes for adaptive aerosol delivery in children with cystic fibrosis McCormack, P.
 2011
 10 S1 p. S54-
1 p.
 artikel
149 277* Outcome following lung transplantation for patients with cystic fibrosis related liver disease: a single centre experience Hester, K.
 2011
 10 S1 p. S70-
1 p.
 artikel
150 136* Overlapping genes as molecular markers for identification of bacteria: the use of marC-hisH for the identification of Burkholderia and Ralstonia Perrin, E.
 2011
 10 S1 p. S34-
1 p.
 artikel
151 238 Paediatric physiotherapy review following the introduction of newborn screening in cystic fibrosis Byrne, N.M.
 2011
 10 S1 p. S60-
1 p.
 artikel
152 271* Pancreatic and biliary secretion differ in cystic fibrosis and wild-type pigs Uc, A.
 2011
 10 S1 p. S69-
1 p.
 artikel
153 344 Patient education: a pedagogic tool for cystic fibrosis transmission and fertility: GENOUTIL David, V
 2011
 10 S1 p. S88-
1 p.
 artikel
154 363 Personality, psychosocial factors and illness effect on adherence behaviour in cystic fibrosis (CF) Braithwaite, M.
 2011
 10 S1 p. S92-
1 p.
 artikel
155 373 p.F508del homozygosity and the genotype-phenotype relationship in Northern Greece Fotoulaki, M.
 2011
 10 S1 p. S95-
1 p.
 artikel
156 92 Phase III study (IMPACTT) on anti-pseudomonas IgY Larsson, A.
 2011
 10 S1 p. S24-
1 p.
 artikel
157 65 Phase 3 study of ataluren (PTC124®) in nonsense mutation cystic fibrosis (nmCF): baseline data Kerem, E.
 2011
 10 S1 p. S17-
1 p.
 artikel
158 128 Population structure of Pseudomonas aeruginosa from cystic fibrosis patients Garcia-Castillo, M.
 2011
 10 S1 p. S33-
1 p.
 artikel
159 265 Practice of chest physiotherapy in adult patients with cystic fibrosis Lacarrière, C.
 2011
 10 S1 p. S67-
1 p.
 artikel
160 67* Preclinical evaluation of preventive hypertonic saline therapy for cystic fibrosis-like lung disease in mice Zhou, Z.
 2011
 10 S1 p. S18-
1 p.
 artikel
161 205 Predictors of time to next exacerbation in adults with cystic fibrosis Dentice, R.L.
 2011
 10 S1 p. S52-
1 p.
 artikel
162 384 Pregnancy and motherhood in women with cystic fibrosis: experience and outcomes in a regional adult UK centre Etherington, C.
 2011
 10 S1 p. S98-
1 p.
 artikel
163 263* Prevalence and impact of urinary incontinence in adult men with cystic fibrosis Button, B.M.
 2011
 10 S1 p. S66-
1 p.
 artikel
164 130 Prevalence of TSST-1-, PVL- and SEA-producing Staphylococcus aureus in cystic fibrosis patients Filleron, A.
 2011
 10 S1 p. S33-
1 p.
 artikel
165 49* Probing the oligomeric state of CFTR Joung, I.
 2011
 10 S1 p. S13-
1 p.
 artikel
166 39* Processing of carrier results following newborn screening for cystic fibrosis: experiences from a UK region Trinick, R.
 2011
 10 S1 p. S10-
1 p.
 artikel
167 389 Prolonged Clostridium difficile associated diarrhoea in a cystic fibrosis patient precluding suitability for lung transplant: an important issue for patients awaiting transplantation O'Brien, D.J.
 2011
 10 S1 p. S100-
1 p.
 artikel
168 234 Proteolysis-antiproteolysis systems in children with bronchial pathology at different levels of fibrosis Gorinova, Y.
 2011
 10 S1 p. S59-
1 p.
 artikel
169 159* Proteomic analysis of the Burkholderia cepacia complex outer membrane proteins involved in adhesion to lung epithelial cells Thomas, M.M.
 2011
 10 S1 p. S40-
1 p.
 artikel
170 199 Pulmonary function and clinical aspects in cystic fibrosis (CF) patients chronically colonized with Pseudomonas aeruginosa Lubovich, S.
 2011
 10 S1 p. S51-
1 p.
 artikel
171 195 Pulmonary function in cystic fibrosis children younger than 3 years old Zaragoza, S.
 2011
 10 S1 p. S50-
1 p.
 artikel
172 382 Quantifying publication bias in cystic fibrosis clinical trials Hurley, M.N.
 2011
 10 S1 p. S98-
1 p.
 artikel
173 381 Registration of clinical trials in cystic fibrosis Elkins, M.R.
 2011
 10 S1 p. S97-
1 p.
 artikel
174 355 Reporting of adverse drug effects in adults and children with cystic fibrosis Hembrow, V.L.
 2011
 10 S1 p. S90-
1 p.
 artikel
175 220 Respiratory and nutritional effects of long-term treatment with azithromycin in patients with cystic fibrosis Fustik, S.
 2011
 10 S1 p. S56-
1 p.
 artikel
176 231* Respiratory muscle function in patients with cystic fibrosis Dassios, T.G.
 2011
 10 S1 p. S58-
1 p.
 artikel
177 117 Results of an on-line survey of cystic fibrosis microbiology practices in UK laboratories Denton, M.
 2011
 10 S1 p. S30-
1 p.
 artikel
178 140 Retrospective analysis of isolation of non-tuberculous mycobacteria from cystic fibrosis sputum samples Burnett, K.
 2011
 10 S1 p. S35-
1 p.
 artikel
179 201* Reversibility of trapped air on CT scans of cystic fibrosis patients, an automated approach Loeve, M.
 2011
 10 S1 p. S51-
1 p.
 artikel
180 328 Review of a paediatric cystic fibrosis (CF) centre to assess changes in outcomes over decade Jaksic, M.
 2011
 10 S1 p. S84-
1 p.
 artikel
181 58 Route of application plays a distinct role for the outcome of a Pseudomonas aeruginosa airway infection in cystic fibrosis mouse models Munder, A.
 2011
 10 S1 p. S15-
1 p.
 artikel
182 124 Saliva IgA antibodies is a diagnostic tool for sinusitis caused by Pseudomonas aeruginosa in patients with cystic fibrosis Aanæs, K.
 2011
 10 S1 p. S32-
1 p.
 artikel
183 378 Saliva sodium and chloride levels: a useful tool for cystic fibrosis (CF) diagnosis? Gonçalves, A.C.
 2011
 10 S1 p. S97-
1 p.
 artikel
184 18 Search for modifier genes in F508del homozygous cystic fibrosis patients Gisler, F.M.
 2011
 10 S1 p. S5-
1 p.
 artikel
185 131 Selective isolation, morphotyping and Spa-typing of Staphylococcus aureus in respiratory tract samples from patients with cystic fibrosis Andersen, C.
 2011
 10 S1 p. S33-
1 p.
 artikel
186 317-Service provision for cystic fibrosis related diabetes (CFRD) in UK CF centres Daniels, J.
 2011
 10 S1 p. S80-
1 p.
 artikel
187 83* Sinonasal inhalation of tobramycin in cystic fibrosis patients with P. aeruginosa colonization of the upper airways – results of a multicentric placebo-controlled pilot study Mainz, J.G.
 2011
 10 S1 p. S21-
1 p.
 artikel
188 75* Small airways response to domase alfa improves using controlled inhalation: a randomized controlled trial in cystic fibrosis patients van den Beukel-Bakker, M.
 2011
 10 S1 p. S19-
1 p.
 artikel
189 385 Smoking, alcohol and drug use in cystic fibrosis patients Huq, S.
 2011
 10 S1 p. S98-
1 p.
 artikel
190 6 Statistical analysis of frequencies of mutations in the cystic fibrosis transmembrane regulator (CFTR) gene and their associations with IVS8 poly-T and Y chromosomal microdeletions Rongioletti, M.C.A.
 2011
 10 S1 p. S2-
1 p.
 artikel
191 221 Subclinical right ventricular dysfunction and pulmonary hypertension detected by echocardiography in adults with cystic fibrosis Zanardelli, M.
 2011
 10 S1 p. S56-
1 p.
 artikel
192 89 Superior effects of RV568, a narrow spectrum kinase inhibitor, on RSV infection in primary bronchial epithelial cells obtained from patients with cystic fibrosis Ito, K.
 2011
 10 S1 p. S23-
1 p.
 artikel
193 372 Survival analysis of cystic fibrosis (CF) patients in the Moscow region of Russia in 2000–2010 Krasovsky, S.
 2011
 10 S1 p. S95-
1 p.
 artikel
194 100* Synergistic effects of a fosfomycin:tobramycin combination on cystic fibrosis pathogens grown aerobically and anaerobically McCaughey, G.
 2011
 10 S1 p. S26-
1 p.
 artikel
195 66 Synthesis of survival evidence in a model of cystic fibrosis disease progression Harrow, B.
 2011
 10 S1 p. S17-
1 p.
 artikel
196 391 Temocillin – drug of choice for Burkholderia cepacia? Hollsing, A.
 2011
 10 S1 p. S100-
1 p.
 artikel
197 56 The calpain-calpastatin system in cystic fibrosis: physiopathological implications Averna, M.
 2011
 10 S1 p. S14-
1 p.
 artikel
198 13 The CFTR S737F(c.2210C>T) mutation: genotype/phenotype correlation in seven subjects Repetto, T.
 2011
 10 S1 p. S4-
1 p.
 artikel
199 171* The chitinase-like protein YKL-40 modulates cystic fibrosis lung disease Hector, A.
 2011
 10 S1 p. S43-
1 p.
 artikel
200 258* The development of a musculoskeletal screening tool for adults with cystic fibrosis Ashbrook, J.E.
 2011
 10 S1 p. S65-
1 p.
 artikel
201 71 The effect of N-acetylcysteine on the visco-elasticity of sputum of cystic fibrosis patients van Daele, S.G.
 2011
 10 S1 p. S18-
1 p.
 artikel
202 282 The effect of social deprivation on weight in the UK cystic fibrosis population Taylor-Robinson, D.
 2011
 10 S1 p. S72-
1 p.
 artikel
203 303 The effect of sunshine on vitamin D levels (25-OHD) in cystic fibrosis (CF) patients – a UK experience Gautam, M.
 2011
 10 S1 p. S77-
1 p.
 artikel
204 331* The German multimodal project “Fit for Life” to optimize the CF-course in children with critical trends – regarding the subject physical activity Moos-Thiele, C.
 2011
 10 S1 p. S84-
1 p.
 artikel
205 337* The German multimodal project “Fit for Life” to optimize the cystic fibrosis course in children with critical trends: first results regarding the initial 12 months period Niemann, N.
 2011
 10 S1 p. S86-
1 p.
 artikel
206 285* The impact of BMI on survival of patients with cystic fibrosis undergoing lung transplantation: a single centre experience Hester, K.
 2011
 10 S1 p. S72-
1 p.
 artikel
207 188 The inflammatory response of in vitro co-culture models of normal and cystic fibrosis (CF) airways to CF-relevant pathogens Bielemeier, A.
 2011
 10 S1 p. S47-
1 p.
 artikel
208 361 The influence of experiential avoidance on depression, anxiety and life quality in adult cystic fibrosis (CF) patients Schusser, S.
 2011
 10 S1 p. S92-
1 p.
 artikel
209 148 The influence of moulds as an independent risk factor for decreasing lung function in cystic fibrosis Guy, C.E.
 2011
 10 S1 p. S37-
1 p.
 artikel
210 377 The new web-based Brazilian CF registry (REBRAFC) Filho, L.V. Silva
 2011
 10 S1 p. S96-
1 p.
 artikel
211 12* The relation between meconium ileus prevalence score and functional severity of CFTR mutations Gonska, T.
 2011
 10 S1 p. S3-
1 p.
 artikel
212 183 The relationship between resting cytokine levels and standard clinical measurements of disease activity in stable adult cystic fibrosis patients O'Connell, O.J.
 2011
 10 S1 p. S46-
1 p.
 artikel
213 376* The role of electronic patient records (EPR) in improving service efficiency and clinical performance in a regional adult UK centre Etherington, C.
 2011
 10 S1 p. S96-
1 p.
 artikel
214 168* The role of novel T helper cell subsets in Pseudomonas aeruginosa immunity Bayes, H.K.
 2011
 10 S1 p. S42-
1 p.
 artikel
215 235 The sensitivity and specificity of cough plates in children with cystic fibrosis Byrne, N.M.
 2011
 10 S1 p. S59-
1 p.
 artikel
216 247 The tolerability of nebulised meropenem within an adult cystic fibrosis centre Parker-Stafford, J.
 2011
 10 S1 p. S62-
1 p.
 artikel
217 321 Timing of inhaled tobramycin affects intravenous tobramycin trough levels Stenbit, A.E.
 2011
 10 S1 p. S82-
1 p.
 artikel
218 194* Understanding the natural progression in FEV1 decline in patients with cystic fibrosis Taylor-Robinson, D.
 2011
 10 S1 p. S49-
1 p.
 artikel
219 364 Unexpected side-effects of a clinical trial Maddison, J.C.
 2011
 10 S1 p. S93-
1 p.
 artikel
220 383 Upper airway pathology in children with cystic fibrosis (CF) Martynova, I.
 2011
 10 S1 p. S98-
1 p.
 artikel
221 272* Ursodeoxycholate reduces cholate biosynthesis rate and pool size in Cftr −/− mice Bodewes, F.A.J.A.
 2011
 10 S1 p. S69-
1 p.
 artikel
222 97 Use of artificial sputum medium to test antibiotic efficacy against Pseudomonas aeruginosa Kirchner, S.
 2011
 10 S1 p. S25-
1 p.
 artikel
223 356* Use of patient monitoring systems in clinical trials to generate objective information on patients' drug adherence of inhaled medications Fuchs, C.
 2011
 10 S1 p. S91-
1 p.
 artikel
224 248* Using an individualized treadmill protocol to assess maximal steady state exercise capacity in cystic fibrosis Morris, A.R.
 2011
 10 S1 p. S63-
1 p.
 artikel
225 147 Utility of Thymus and Activation Regulated Chemokine (TARC) in serodiagnosis of ABPA in a paediatric cystic fibrosis population Williams, C.
 2011
 10 S1 p. S37-
1 p.
 artikel
226 379 Utilization and healthcare charges in an insured US cystic fibrosis (CF) patient population Broder, M.S.
 2011
 10 S1 p. S97-
1 p.
 artikel
227 256 Validation of the international physical activity questionnaire (IPAQ) in adults with cystic fibrosis Button, B.M.
 2011
 10 S1 p. S65-
1 p.
 artikel
228 387 Validation of the Spanish version of the Leicester Cough Questionnaire in children with cystic fibrosis Persegona, J.
 2011
 10 S1 p. S99-
1 p.
 artikel
229 332* Validation of the treatment satisfaction questionnaire for medication (TSQM) in cystic fibrosis (CF) Regnault, A.
 2011
 10 S1 p. S85-
1 p.
 artikel
230 70 Vardenafil as anti-inflammatory drug in the treatment of cystic fibrosis lung disease Lubamba, B.
 2011
 10 S1 p. S18-
1 p.
 artikel
231 338 Variability of clinical outcomes and impact of risk factors in cystic fibrosis (CF) patients in a regional CF center in a developing country Dracea, L.-L.
 2011
 10 S1 p. S86-
1 p.
 artikel
232 185* Variability of toll like receptor mediated innate immune response in patients with cystic fibrosis and their relationship with clinical phenotype O'Connell, O.J.
 2011
 10 S1 p. S47-
1 p.
 artikel
233 157 Variation in canide production between different strains of Pseudomonas aeruginosa Gilchrist, F.J.
 2011
 10 S1 p. S40-
1 p.
 artikel
234 298 Vitamin deficiency in children with cystic fibrosis Olesen, A.M.
 2011
 10 S1 p. S75-
1 p.
 artikel
235 299 Vitamin D status in pancreatic sufficient children with cystic fibrosis – are we doing enough? Orchard, W.A.
 2011
 10 S1 p. S76-
1 p.
 artikel
236 302 Vitamin D supplementation in children with cystic fibrosis: sunshine, cholecalciferol and ergocalciferol Homola, L.
 2011
 10 S1 p. S76-
1 p.
 artikel
237 304 Vitamin K status in young children with cystic fibrosis Krzyzanowska, P.
 2011
 10 S1 p. S77-
1 p.
 artikel
238 246* What is the level of understanding about nebuliser therapy in patients attending an adult cystic fibrosis clinic? Lloyd, E.
 2011
 10 S1 p. S62-
1 p.
 artikel
239 241 When should lung function test be performed to evaluate the effects of an airway clearance therapy session in children and adults with cystic fibrosis? Hortal, M.C. Rodriguez
 2011
 10 S1 p. S61-
1 p.
 artikel
240 41* Who should be analyzed in a cystic fibrosis registry? Thomas, M.
 2011
 10 S1 p. S10-
1 p.
 artikel
                             240 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland